BETA DRUGS
Back to Balance Sheet
|
BETA DRUGS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹113 Cr | ₹94 Cr | ₹70 Cr | ₹55 Cr | ₹37 Cr |
What is the latest Total Current Liabilities ratio of BETA DRUGS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹113 Cr |
| Mar2024 | ₹94 Cr |
| Mar2023 | ₹70 Cr |
| Mar2022 | ₹55 Cr |
| Mar2021 | ₹37 Cr |
How is Total Current Liabilities of BETA DRUGS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹113 Cr | 20.11 | |
| Mar2024 | ₹94 Cr | 35.43 | |
| Mar2023 | ₹70 Cr | 27.09 | |
| Mar2022 | ₹55 Cr | 49.90 | |
| Mar2021 | ₹37 Cr | - | |
Compare Total Current Liabilities of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,570.3 Cr | -5.1% | 7% | 32.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -5.1% |
7% |
32.4% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses